We serve (fmoc-cys-otbu)2, (disulfide bond) CAS:139592-37-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: (fmoc-cys-otbu)2, (disulfide bond)
CAS.NO: 139592-37-3
Molecular Formula:C44H48N2O8S2
Molecular Weight: 796.99100
Synonyms:
Bis(2-methyl-2-propanyl) N,N'-bis[(9H-fluoren-9-ylmethoxy)carbonyl]-L-cystinate
L-Cystine, N,N'-bis[(9H-fluoren-9-ylmethoxy)carbonyl]-, bis(1,1-dimethylethyl) ester
(Fmoc-Cys-OtBu)2
Physical and Chemical Properties:
Density: 1.3±0.1 g/cm3
Boiling point: 905.0±65.0 °C at 760 mmHg
Flash point:501.1±34.3 °C
Refractive index:1.607
Specification:
Appearance: White Crystalline Powder
Purity:≥98%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store at 0-5ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:pharmaceutical intermediates.
Contact us for information like (fmoc-cys-otbu)2, (disulfide bond) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(Fmoc-Cys-OtBu)2 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Bis(2-methyl-2-propanyl) N,N’-bis[(9H-fluoren-9-ylmethoxy)carbonyl]-L-cystinate Use and application,L-Cystine, N,N’-bis[(9H-fluoren-9-ylmethoxy)carbonyl]-, bis(1,1-dimethylethyl) ester technical grade,usp/ep/jp grade.
Related News: GlaxoSmithKline (GSK) is at the bottom of the top 20 list with the lowest percentage R&D spend/annual revenue at 12%.”7-bromo-1-heptanol acetate manufacturer Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.4-Chloro-3-nitrobenzoic Acid supplier Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.1-(2-Chloro-4-(4-chlorophenyl)butyl)-1H-imidazole vendor Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.
